The Platinum Study Comparison Group

Completed

Conditions studied: Testicular Neoplasms

In brief

The patients enrolled on this new study will serve as an appropriate comparison group consisting of patients with the diagnosis of germ cell testicular cancer who were cured with surgical resection and did not receive cisplatin-based chemotherapy with a group of patients from another study who did receive cisplatin-based chemotherapy.

Key facts

Study ID

NCT02890030

Run by

Lawrence Einhorn

People needed

102

Starts

2015-05-01

Expected to finish

2017-06-14

Last updated by the study team

2020-04-08

Who can join

Age: 18 and older, up to 55. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis or confirmation of diagnosis of a histologically or serologically confirmed testicular germ cell tumor (GCT) or GCT at another anatomic location
• Age at GCT diagnosis: 55 years of age or younger
• Males, 18 years of age or older at time of study consent
• Subject is able to provide consent
• Subject is able to speak and read English
• Treatment consisted of surgery only (i.e., orchiectomy and/or retroperitoneal lymph node dissection [RPLND]) for either initial testicular germ cell tumor (GCT) or subsequent testicular cancer
• Subject completed surgery > 1 year ago
• Subject is currently undergoing active follow-up at IU
• Subject did not require any subsequent chemotherapy, salvage chemotherapy treatment or bone marrow transplant.
• Subject had no prior chemotherapy of any kind

You may not qualify if…

• Patients with prior chemotherapy (whether for GCT or any other cancer)

Where it is running

• Indiana University Melvin and Bren Simon Cancer Center — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.